12.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DYN Giù?
Forum
Previsione
Dyne Therapeutics Inc Borsa (DYN) Ultime notizie
Applying big data sentiment scoring on Dyne Therapeutics Inc.July 2025 Trends & AI Driven Price Forecasts - newser.com
Applying Elliott Wave Theory to Dyne Therapeutics Inc.2025 Price Action Summary & Intraday High Probability Setup Alerts - newser.com
How Dyne Therapeutics Inc. stock performs in high volatility marketsJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Dyne Therapeutics, Inc. (DYN) Stock Analysis: 178.4% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Technical signs of recovery in Dyne Therapeutics Inc.Options Play & Risk Controlled Stock Pick Alerts - newser.com
United States Myotonic Dystrophy Treatment Market Set for Rapid - openPR.com
Dyne Therapeutics Inc. stock momentum explainedRate Hike & Verified Momentum Stock Watchlist - newser.com
Will Dyne Therapeutics Inc. stock keep outperforming rivalsTrade Risk Report & Daily Profit Maximizing Tips - newser.com
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 7.2%Here's Why - MarketBeat
Dyne Therapeutics (DYN) Gains Orphan Drug Status in Japan for Du - GuruFocus
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 to Treat Duchenne Muscular Dystrophy - MarketScreener
Dyne Therapeutics receives orphan drug designation in Japan for DYNE-251 in Duchenne muscular dystrophy - MarketScreener
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy - GlobeNewswire
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy - Benzinga
Is Dyne Therapeutics Inc. stock a smart buy before Fed meetingDip Buying & Free Reliable Trade Execution Plans - newser.com
Can Dyne Therapeutics Inc. stock hit analyst price targetsTrade Risk Report & AI Driven Stock Reports - newser.com
Will Dyne Therapeutics Inc. stock sustain high P E ratiosDollar Strength & Real-Time Market Trend Scan - newser.com
Published on: 2025-09-29 02:45:54 - newser.com
Using Python tools to backtest Dyne Therapeutics Inc. strategiesJuly 2025 Pullbacks & Real-Time Chart Pattern Alerts - newser.com
What risks investors should watch in Dyne Therapeutics Inc. stockPortfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Voya Investment Management LLC Sells 200,017 Shares of Dyne Therapeutics, Inc. $DYN - MarketBeat
Aug Patterns: Is Dyne Therapeutics Inc on track to beat earningsJuly 2025 Update & Verified Chart Pattern Signals - خودرو بانک
Inflation Data: Can Dyne Therapeutics Inc disrupt its industryTake Profit & Fast Exit Strategy with Risk Control - khodrobank.com
Short Squeeze: Is Dyne Therapeutics Inc forming a double bottomJuly 2025 Movers & Growth Focused Stock Reports - خودرو بانک
Aug Action: Will Dyne Therapeutics Inc. benefit from government policyPortfolio Return Summary & AI Powered Buy and Sell Recommendations - khodrobank.com
First Week of November 21st Options Trading For Dyne Therapeutics (DYN) - Nasdaq
Can Dyne Therapeutics Inc. be recession proof2025 Geopolitical Influence & Long-Term Safe Investment Ideas - خودرو بانک
Signal Recap: Can Dyne Therapeutics Inc. ride the EV waveInflation Watch & Smart Allocation Stock Reports - khodrobank.com
Risk Off: Is Dyne Therapeutics Inc stock a smart retirement pickQuarterly Profit Review & Verified Momentum Stock Ideas - خودرو بانک
Will Dyne Therapeutics Inc. see short term momentumQuarterly Profit Review & Consistent Return Strategy Ideas - newser.com
Market Moves: Can Dyne Therapeutics Inc. expand its profit marginsDip Buying & Free High Return Stock Watch Alerts - خودرو بانک
Dyne Therapeutics (NASDAQ:DYN) Shares Down 3.7%Should You Sell? - MarketBeat
What to do if you’re stuck in Dyne Therapeutics Inc.July 2025 Review & Comprehensive Market Scan Reports - newser.com
Smart Money: Is Dyne Therapeutics Inc forming higher highs and higher lows2025 Technical Patterns & AI Powered Market Entry Strategies - خودرو بانک
Market Wrap: Is Dyne Therapeutics Inc being accumulated by smart moneyJuly 2025 Reactions & Community Trade Idea Sharing Platform - خودرو بانک
Market Overview: Will BlackRock Innovation and Growth Term Trust outperform small cap indexesJuly 2025 Setups & Advanced Technical Signal Analysis - خودرو بانک
Dyne Therapeutics Advances DMD Treatment with DYNE-251 Study - MSN
Rally Mode: Will Erasca Inc. benefit from AI trendsJuly 2025 Outlook & Risk Controlled Stock Pick Alerts - خودرو بانک
New Highs: Will Dyne Therapeutics Inc benefit from current market trendsMarket Growth Report & Risk Managed Investment Strategies - خودرو بانک
Risk vs reward if holding onto Dyne Therapeutics Inc.Buy Signal & Fast Gain Swing Alerts - newser.com
Voleon Capital Management LP Takes $624,000 Position in Dyne Therapeutics, Inc. $DYN - MarketBeat
Aug PreEarnings: Is Dyne Therapeutics Inc gaining market shareJuly 2025 Price Swings & Daily Market Momentum Tracking - خودرو بانک
Market Overview: Is Tactile Systems Technology Inc. being accumulated by smart moneyJuly 2025 Breakouts & Verified Momentum Watchlists - خودرو بانک
Visual trend scoring systems applied to Dyne Therapeutics Inc.Weekly Gains Summary & Daily Stock Trend Watchlist - newser.com
Breakout Move: Can Dyne Therapeutics Inc deliver consistent dividends2025 Key Lessons & Weekly Watchlist for Consistent Profits - خودرو بانک
Aug Highlights: Is Dyne Therapeutics Inc forming a double bottomWeekly Trade Report & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Is TOMI Environmental Solutions Inc.’s ROE strong enoughJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - خودرو بانک
Is now a turning point for Dyne Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What hedge funds are buying Dyne Therapeutics Inc2025 Earnings Surprises & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Exome Asset Management LLC Acquires Shares of 258,391 Dyne Therapeutics, Inc. $DYN - MarketBeat
John Cox Sells 2,640 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):